About Us
The Future of Medicine Starts
With Better Questions
For decades, medicine has become increasingly specialized—dividing health into diseases, organs, symptoms, and treatments.
We became interested in what connects them.
Across recovery, aging, chronic disease, and human performance, we saw the same biological themes appearing again and again. Not because these conditions are the same, but because the body relies on a remarkably interconnected set of systems to maintain balance.
That realization sparked a simple but ambitious pursuit: understanding the biology of resilience and work in coordinated elegance with it.
Today, Sen-Jam brings together pharmacology, systems biology, computational discovery, and clinical insight to explore how preserving resilience may change the way we think about health, recovery, and disease itself.
Our Philosophy
Intellectual Honesty
The data decides.
Biology First
Disease labels change. Biology doesn't.
Precision Over Force
Better targeting beats bigger intervention.
Safety by Design
Safety is not a checkpoint. It's a starting point.
Start Earlier
Preserve resilience before dysfunction becomes damage
Meet the Executive Team
Jacqueline
Iversen, RPh, MS
Co-Founder, Chief Clinical Officer
Jim
Iversen
Co-Founder, CEO
Tom
Dahl
Head of Regulatory Affairs
Christine
Leonard
Head of Strategy
Neal
Zahn
Head of Global Licensing
Meet the Advisors
Ashley
St. John PhD
Immunology Expert
Gary
Zammit PhD
Drug Development Expert
Francis
Farraye MD, MSC
IBD Expert + Thought Leader
Andrew
Scholey PhD
Neuroscience Expert
Alexander
Wissner-Gross PhD
Futurist, AI-Expert
